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LINE-1 or L1 is an autonomous non-LTR retrotransposon in mammals. Retrotransposition requires the function of the two L1-
encoded polypeptides, ORF1p and ORF2p. Early recognition of regions of homology between the predicted amino acid sequence
of ORF2 and known endonuclease and reverse transcriptase enzymes led to testable hypotheses regarding the function of ORF2p
in retrotransposition. As predicted, ORF2p has been demonstrated to have both endonuclease and reverse transcriptase activities.
In contrast, no homologs of known function have contributed to our understanding of the function of ORF1p during retrotrans-
position. Nevertheless, signiﬁcant advances have been made such that we now know that ORF1p is a high-aﬃnity RNA-binding
protein that forms a ribonucleoprotein particle together with L1 RNA. Furthermore, ORF1p is a nucleic acid chaperone and this
nucleic acid chaperone activity is required for L1 retrotransposition.
Copyright © 2006 Sandra L. Martin. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LINE-1 BACKGROUND
L1 is an interspersed repeated DNA found in mammalian
genomes that attained its high copy number by retrotrans-
position. It belongs to a large family of mobile elements
that replicate via reverse transcription of an RNA inter-
mediate. These elements, non-LTR retrotransposons, are
distinct from retroviruses and LTR-containing retrotrans-
posons which also replicate via reverse transcription of an
RNA intermediate. Non-LTR retrotransposons are widely
distributed throughout eukaryotes and likely all share the
novel mechanism of replication known as target-site-primed
reverse transcription, or TPRT, whereby reverse transcrip-
tion of the L1 RNA template is primed from a 3 hydroxyl
at the genomic insertion site (reviewed in [1]).
Close inspection of sequences of the > 500,000 copies
of either mouse or human L1 reveals a multigene fam-
ily comprised mainly of truncated, mutated, or rearranged
copies of a small number of functional, full-length elements;
only a subset of the full-length elements is capable of retro-
transposition (see [2, 3], for recent reviews). The functional
retrotransposons are 6-7kb in length and contain two long
open reading frames (ORFs), both of which encode pro-
teins that are required for retrotransposition [3]. ORF2 en-
codes a 146kd polypeptide which provides the two known
enzymatic activities that are required to convert the RNA
intermediate into a new genomic DNA copy of L1 during
TPRT: endonuclease [4] and reverse transcriptase [5]. These
two activities of ORF2p were predicted from sequence simi-
laritybetweenL1andknownapurinic/apyrimidinicendonu-
clease [4] and reverse transcriptase [6, 7] proteins, then ver-
iﬁed biochemically [4, 8]. In contrast, the role of ORF1p
during retrotransposition has remained far more elusive be-
cause the amino acid sequence predicted by ORF1 lacks
homology with any protein of known function (see [9],
and results of October 2005 NCBI protein and nucleotide
searches).
ORF1 AND RELATED SEQUENCES
The ﬁrst intact coding sequence for an ORF1 protein was
found by sequence analysis of a mouse L1 element called
L1Md-A2 [7]. Comparison of the theoretical translation of
this 41.2kd protein from L1Md-A2 to that of a consen-
sus primate L1 sequence revealed that the C-terminal half
of ORF1 was evolving under selective pressure, whereas
the N-terminal half was not. This early analysis also noted
that the predicted ORF1 protein is quite basic, a common
feature of nucleic acid-binding proteins [7]. Subsequently,
many ORF1-like sequences have been determined from the
L1 elements of diﬀerent mammals, and from related ele-
mentsfoundinﬁsh[16].TheC-terminal,homologous,basic2 Journal of Biomedicine and Biotechnology







Figure 1: Schematic representation of the ORF1 protein. The thin
bar for each species represents the entire length of the protein.
Thicker bars represent the coiled-coil (gray, based upon coils anal-
ysis [10]) and conserved domains (black, based upon multiple-
sequencealignmentsusingT-Coﬀee[11]).Thesetwodomainsover-
lap in the human, rabbit, and ﬁsh, but not the two mouse or rat
ORF1 protein sequences, as indicated. Sequences used were mouse
A101 (Q91V68l, [12]), mouse L1spa (O54849, [13]), rat (Q63303),
human L1rp (AAD39214, [14]), rabbit ([15], not in GenBank), and
ﬁsh swimmer (AAD02927, [16]). The two mouse and the human
ORF1 protein sequences are from retrotransposition-competent el-
ements; the other sequences are from untested elements. A model
forthetrimericstructureofmouseL1anditsroleinTPRTappeared
in [17]b yM a r t i ne ta l .
domain is a general feature of the ORF1 proteins from all of
these elements (the conserved domain in Figure 1).
A second predicted feature of all of these ORF1 amino
acid sequences is the presence of a long coiled-coil domain
upstream of the conserved domain (Figure 1). In human L1,
thiscoiled-coildomainencompassesaleucinezipper[18].In
rabbit ORF1, this coiled-coil region appears similar to ker-
atin [15]. The most likely explanation for the poor sequence
similarity among the diﬀerent ORF1 sequences in this region
with one another and with other coiled-coil-containing pro-
teins (eg, keratin) is that all share a coiled-coil domain with
distinct evolutionary origins, probably brought into proxim-
ity with the conserved, basic C-terminal domain via recom-
bination. Recombination to create novel sequence variants is
often evident in L1 lineages [19–23]. With this scenario, the
constraintsimposedbyarequirementforprotein-proteinin-
teraction via a coiled-coil domain in ORF1 protein forces a
small degree of apparent similarity in the absence of homol-
ogy among these diverse sequences. Conversely, it is possi-
ble that all of these ORF1 sequences evolved from a common
ancestor, but extremely rapid divergence of the sequences to-
wards the N-terminus of the protein has obscured the evi-
dence for this homology. Interestingly, sequence variation in
this N-terminal region of ORF1p is particularly great within
subtypes of human [24], rat (see [2], and references therein),
and mouse (see [25, 26], and references therein) L1. Posi-
tive selection acting within this portion of the ORF1 protein
is associated with the evolutionary success/extinction of hu-
man L1 lineages, perhaps reﬂecting drive for ORF1p to ei-
ther attract or avoid an interacting factor [24]. Additional se-
quences from L1 elements in other species may shed light on
whether the amino acid sequence of the N-terminal region
is undergoing strong selective pressure for rapid sequence
divergence by accumulating replacement substitutions, or if
novel sequences are often acquired from nonhomologous
sources.
An unexpected feature of the L1 ORF1 sequence is re-
vealed when its amino acid sequence is used as the query
in a BLASTP search. The program reports that it has de-
tected a putative conserved domain. This conserved domain
is essentially the entire mammalian ORF1 protein sequence
and has been annotated “transposase 22.” Given that trans-
posase is the enzyme responsible for the DNA breaking-
joining reactions that occur during transposition of a wide
variety of DNA elements [27], it seems likely to be a mis-
nomer to call this domain a transposase for several reasons.
Most signiﬁcantly, the TPRT reaction used by L1 and the
other non-LTR retrotransposons does not require a trans-
posase enzymatic activity because cDNA is synthesized in
situ using chromosomal primers [28]. Thus, L1 replication
lacks any intermediate equivalent to the double-strand DNA
substrate of transposases and the related integrases [27].
Futhermore, biochemical and mutational analyses demon-
stratethattheendonucleaseactivityofL1ORF2pisresponsi-
blefortheDNAcleavagesthatoccurduringTPRT[4,29,30].
Finally, the conserved domain in ORF1p of known func-
tional mouse and human L1 elements lacks an apparent
DDE motif [31], which is conserved in the active sites of
transposases and integrases. Due to vast sequence divergence
among members of the transposase/integrase superfamily of
proteins, their DDE motifs are best recognized in structure
[32] rather than sequence alignments; hence absolute resolu-
tion of the question of whether L1 ORF1p should be anno-
tated “transposase 22” awaits atomic-level resolution of its
structure.
ORF1p IS REQUIRED FOR RETROTRANSPOSITION
Even the relatively conserved C-terminal domain of ORF1 is
more divergent than ORF2 when the sequences of human
and mouse L1s are compared [7]. Hence, when it was ﬁ-
nally possible to measure L1 retrotransposition activity us-
ing an autonomous retrotransposition assay [5, 33], it was
unexpected to learn that mutations in ORF1 were at least as
severe, if not more so, than those that abolish reverse tran-
scriptase activity. No retrotransposition events were detected
in human L1 mutants in which either the serine at position
119 of ORF1p was replaced with a stop codon, or a highly
conserved diarginine at 261/262 was replaced by dialanine;
in both of these cases, the frequency of retrotransposition
was less than 0.06% of the wild-type parental element. In
contrast, mutation of a critical active-site residue in the re-
verse transcriptase domain of ORF2 (D702Y), which abol-
ishes in vitro enzymatic activity [8], knocked retrotranspo-
sition down to 0.15% of wild type [5]. The other known
enzymatic activity of ORF2 in L1 is endonuclease, which is
also required for TPRT [34]. Several mutations that elimi-
nate detectable endonuclease activity in an in vitro nicking
assay again knock retrotransposition down to 0.2–1%, but
do not eliminate it [34]. We observe similar eﬀects of mu-
tations in the ORF1 conserved domain compared to the en-
donuclease and reverse transcriptase domains in mouse L1.Sandra L. Martin 3
Thus,todate,themoststringentmutationsofL1arethosein
ORF1. As noted when the leakiness of the ORF2 mutations
wasoriginallyobserved,itislikelythatORF2pismorereadily
suppliedin trans (albeit with substantially reducedeﬃciency,
[5]),whereasORF1pappearstobemorestringentlyrequired
in cis with the L1 RNA. These ﬁndings imply that ORF1 is
critical for an earlier step in the retrotransposition cycle than
reverse transcription itself, for example, regulating expres-
sion of ORF2 [35] or recruitment of ORF2p into the L1 ri-
bonucleoprotein complex, and/or delivering the L1 RNP to
the chromosomal DNA and facilitating the strand exchanges
that are required during TPRT [17, 36].
In light of the stringent cis-requirement for ORF1p dur-
ing L1 retrotransposition, it is interesting that ORF1p ap-
pears to be dispensable when the L1 machinery provided
by ORF2p is usurped by the human SINE, Alu, for its
ampliﬁcation—this surprising ﬁnding may be explained if
the SRP9/14 protein can replace ORF1p function [37]. In
contrast, ORF1p is required along with ORF2p for processed
pseudogene formation by L1 [38, 39].
FUNCTIONAL ANALYSIS OF ORF1p:
PROTEIN-PROTEIN INTERACTION
Leucine zippers and coiled-coil domains are typically as-
sociated with protein-protein interactions. In cytoplasmic
extracts from human cells that express high levels of L1,
NTera2D1, the ORF1p (also called p40) partitions into a
160,000 x g pellet. Treatment of this pellet with increasing
concentrations of glutaraldehyde to cross-link the protein
shifts increasing amounts of the 40kd ORF1 protein into
complexes that run at 78, 89, 100, and 200kd on SDS-PAGE,
suggesting that the ORF1ps in these cytoplasmic particles are
interacting closely with one another, or with other cellular
proteins. This study also examined full-length p40 and vari-
ous truncations expressed in Ec o l ifor protein-protein inter-
actions, thereby mapping the multimerization domain to the
N-terminal half of the protein, in the region of the predicted
coiled-coil [9].
Similar ﬁndings were obtained with mouse L1 ORF1p
using somewhat diﬀerent experimental approaches. Recom-
binant protein puriﬁed from Ec o l icoimmunoprecipitated
35S-labeled protein synthesized in vitro in rabbit reticulo-
cyte lysate, demonstrating that mouse ORF1p is able to
self-associate [40]. A combination of yeast 2-hybrid and
GST pull-down assays were later used to map the region
in mouse ORF1p responsible for multimerization; the pre-
dicted coiled-coil domain is both necessary and suﬃcient
for protein-protein interaction [41]. More recently, overex-
pression of soluble ORF1p in baculovirus permitted analy-
sis of its multimerization state by analytical ultracentrifuga-
tion.Thesestudiesrevealedthatthefull-lengthproteinforms
a highly stable homotrimer, whereas a truncated ORF1p
containing just the carboxy-terminal C-1/3 does not self-
associate, even at relatively high protein concentrations [17].
All of the above ﬁndings consistently support the conclusion
that the coiled-coil domain is wholly responsible for mul-
timerization in both mouse and human L1 ORF1ps, with
the trimer being the biologically relevant form of mouse
ORF1p [17].
FUNCTIONAL ANALYSIS OF ORF1p:
NUCLEIC ACID BINDING
The bias towards highly basic amino acids in ORF1p led to
the hypothesis that this protein interacts with nucleic acids
[7]. Early evidence for such interaction was provided by
cosedimentationofORF1pwithL1RNAinsucrosegradients
loaded with cytoplasmic extracts prepared from the mouse
embryonal carcinoma cell line F9. The heavy complexes that
formed were termed L1 ribonucleoprotein particles, or L1
RNP. L1 RNPs are not sensitive to disruption by EDTA, but
are sensitive to proteolysis [42]. Exposure of the RNPs to
UV light rapidly cross-links the RNA to protein, indicating a
close association between L1 RNA and protein [21]. The hu-
man ORF1p (p40) also associates with L1 RNA based upon
a series of cosedimentation experiments. p40 remains in the
supernatant upon centrifugation at 800 and 12,000x g,b u t
pellets at 160,000x g. Treatment of the cytoplasmic extract
(800x g supernatant) with RNase but not DNase prior to
centrifugation shifts p40 from the 160,000x g pellet to the
supernatant, indicating that the protein is pelleting because
it is in a large complex with RNA, or an RNP. The human L1
RNPs are not dependent on divalent cations or disturbed by
10mM EDTA, thus it appears that human ORF1p is bound
to RNA in an RNP that is quite similar to the mouse L1 RNP.
Further experiments indicated that the RNA present in these
RNP was L1 RNA and not actin or G3PDH RNA [9]. The
presence of ORF1p in RNP was found to be sensitive to high
concentrations of monovalent cations as well as RNase treat-
ment [43, 44], leading to an enrichment procedure for RNA-
free ORF1p from human cells [43], which was then used to
provide evidence for one or two relatively high-aﬃnity bind-
ing sites for ORF1p in L1 RNA [35]. It is important to note
that all of the above experiments examined the interaction of
L1 RNA with ORF1p in extracts from animal cells where L1
RNA and ORF1p were present as minority components of a
complex mixture.
A more direct assessment of the nucleic acid-binding
properties of the ORF1 protein is provided by studies of
highly puriﬁed protein prepared after overexpression in ei-
ther Ec o l ior baculovirus-infected insect cells. As with
ORF1p from mammalian cells, it is critical to take precau-
tions against copuriﬁcation of RNA with the protein—when
protein is puriﬁed in standard, nondenaturing conditions
without high concentrations of monovalent cation, RNA is
coenriched and the protein is heavily contaminated with nu-
cleic acid. This is readily apparent on a wavelength scan, or
by examining puriﬁed protein by ethidium bromide stain-
ing after electrophoresis through agarose gels [41]. Our ear-
liest experiments with protein expressed in Ec o l iused de-
naturing conditions (8M urea) to purify the protein from
the insoluble inclusion body fraction which simultaneously
removed bound nucleic acid. That protein was used for
UV cross-linking and electrophoretic mobility-shift assays
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single-stranded DNA [40]. The aﬃnities observed in those
experiments, however, were lower than those obtained with
subsequent experiments that were done using protein puri-
ﬁed from the soluble fraction rather than the refolded dena-
tured protein from inclusion bodies, probably because most
of the protein wasnot correctlyrefolded to its native form af-
ter the denaturation. Interestingly, the RNA-binding region
of the full-length ORF1p was mapped by simply examin-
ing various GST-ORF1p fusion constructs (containing full-
length and a variety of truncated regions of ORF1p) for the
presence of copurifying RNA. As long as the Ec o l iextracts
andaﬃnitypuriﬁcationstepswerekeptinphysiologicalcon-
centrations of monovalent cation, RNA copuriﬁed with the
protein if it contained the RNA-binding domain. All dele-
tions containing the C-1/3 basic domain were contaminated
with RNA and those that lacked it were free of RNA con-
tamination. This same region of mouse ORF1p was found
to be both necessary and suﬃcient for binding nucleic acid
basedupontransferof 32P from RNA to protein by UV cross-
linking [41].
The RNA-binding properties of the full-length mouse
ORF1 protein puriﬁed from baculovirus were further as-
sessed using coimmunoprecipitation and ﬁlter-binding as-
says. These experiments examined the aﬃnity of ORF1p for
a variety of transcripts, and tested whether a speciﬁc cis-
acting sequence in mouse L1 RNA recruits ORF1p. The pres-
ence of a high-aﬃnity site in human L1 RNA was suggested
based upon preferential coimmunoprecipitation of a 41nt
T1 nuclease-resistant fragment with ORF1 antibody [35].
The mouse L1 RNA coimmunoprecipitation experiments re-
vealedthateﬃcientrecoveryofthe 32P-labeledRNArequired
atleast38nt,suggestingalengtheﬀectratherthanasequence
requirement. All longer RNAs tested precipitated eﬃciently,
independent of sequence. Further evidence that ORF1p is a
nonsequence-speciﬁc RNA-binding protein was provided by
results of nitrocellulose ﬁlter-binding assays using highly pu-
riﬁed mouse ORF1p expressed in baculovirus. Transcripts
that contained speciﬁcally the 38nt sequence in either the
sense or antisense orientation both bound with high aﬃn-
ity. Although there is a slight increase in the apparent bind-
ing aﬃnity of ORF1p to RNA containing the sense 38nt se-
quence compared to the same sequence in antisense orienta-
tion, it is only 4- to 7-fold and therefore too small to be con-
sidered speciﬁc binding for sense versus antisense L1 RNA
[45].
Thisdiscrepancybetweentheresultswithmouseandhu-
man L1 ORF1ps regarding the existence of a high-aﬃnity
binding site within L1 RNA has not been resolved. Possibly,
it is due to diﬀerences between mouse and human L1, or,
more likely, between the reagents used for the assays. For ex-
ample, it is possible that another protein that is critical for
thesite-speciﬁcitywaspresentinthepartiallypuriﬁedprepa-
ration from human cells, but missing when the protein was
puriﬁed from baculovirus-infected insect cells or Ec o l i .T h e
questionofwhetherL1RNAcontainsaspeciﬁc,high-aﬃnity
binding site for ORF1p is important for L1 biology because
it oﬀers an attractive explanation for the cis-preference of
ORF1p for L1 RNA that is evident from both the evolution-
ary pattern of L1 as well as experimental evidence from the
autonomous retrotransposition assay (see [38, 39], and ref-
erences therein).
FUNCTIONAL ANALYSIS OF ORF1p:
NUCLEIC ACID CHAPERONE ACTIVITY
Non-LTR retrotransposons are present throughout Eukary-
ota, but diverged long ago into ﬁve groups based upon the
phylogenetic relationships of their reverse transcriptase re-
gion (the only sequence feature conserved among all non-
LTRretrotransposons)andthetypeandorganizationoftheir
proteindomains[1].Threeofthesegroups,L1,I,andJockey,
each named for the ﬁrst element of that group described,
have a separate ORF upstream of their reverse transcriptase-
containing ORF. In two of these three groups, I and Jockey,
theupstreamORFs(ie,ORF1s),bothcontainzinc-ﬁngerdo-
mains, making their ORF1 proteins reminiscent of retrovi-
ral gag proteins. An important function associated with the
zinc-ﬁnger-containing,nucleocapsiddomainofgagisthatof
nucleic acid chaperone, which is critical for retroviral repli-
cation [46]. Nucleic acid chaperones are proteins that fa-
cilitate rearrangements of nucleic acids to their thermody-
namically most stable form. A combination of at least three
protein features contribute to nucleic acid chaperone activ-
ity: charge neutralization due to an excess of basic amino
acids, a higher aﬃnity for single-stranded than for double-
stranded nucleic acids, and the ability to lower the coop-
erativity of the helix: coil transition [47]. These properties
must be exquisitely balanced so that the chaperone can pro-
mote both melting and annealing of nucleic acids. The ORF1
protein from the non-LTR retrotransposon, I factor, shares
several biochemical properties with retroviral nucleocapsid
proteins,includingtheabilitytoaccelerateannealingofcom-
plementarysingle-strandDNAsequences;theseobservations
led to thesuggestionthatthe IfactorORF1protein functions
as a nucleic acid chaperone during replication [48].
Mouse L1 ORF1 protein also accelerates annealing of
complementary oligonucleotides. In addition, it lowers the
Tm of mispaired duplex DNA, accelerates a strand displace-
ment reaction if an imperfect duplex is challenged by the
addition of the perfect complement, and alters the force re-
quiredforthehelix: coiltransition insingle-molecule studies
using optical forceps [36, 49]. Signiﬁcantly, the nucleic acid
chaperone activity of ORF1p is required for retrotransposi-
tion. A single-point mutation that destroys eﬀective chap-
erone activity (R297K) without aﬀecting RNA or single-
stranded DNA binding aﬃnity also destroys retrotransposi-
tion activity [49]. Consistent with this observation, the anal-
ogous mutation in human L1 also destroys retrotransposi-
tion, but not RNP formation [44].
SUMMARY
L1 is arguably the most signiﬁcant dynamic force currently
operating upon the mammalian genome. Retrotransposition
is just one of many facets of L1’s contribution to genetic
plasticity and diversity [50], although it lies at the root ofSandra L. Martin 5
all of the others. Retrotransposition requires the proteins
encoded by both of the two open reading frames in L1. The
two known functions of the protein encoded by ORF2, en-
donuclease and reverse transcriptase, were readily predicted
b a s e du p o ns e q u e n c eh o m o l o g y ,w h e r e a sh o m o l o g yh a ss o
farfailedtoprovidecluesregardingthefunctionoftheORF1
protein. In spite of this disadvantage, however, several sig-
niﬁcant advances have been made in establishing the struc-
ture and function of this critical retrotransposition protein
though a series of in vivo and in vitro experiments. The
protein binds both RNA and DNA, with a higher aﬃnity
for single-stranded than double-stranded nucleic acids. The
RNA-binding function leads to RNP formation and safe de-
livery of the RNP to genomic DNA so that it can undergo
TPRT. The nucleic acid chaperone activity of ORF1p likely
contributes more directly to reverse transcription by TPRT,
perhaps by facilitating the strand exchanges that place the
DNA primer onto the RNA or cDNA template, or by melt-
ing secondary structure in the RNA, or both.
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